Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the FAERS Database

This study provides real-world evidence for the safety evaluation of upadacitinib and underscores the need to monitor sex-specific adverse events. Future prospective studies are necessary to confirm these pharmacovigilance findings.